Retraction Note: Aurora-A is a determinant of tamoxifen sensitivity through phosphorylation of ERα in breast cancer

Oncogene. 2024 Apr;43(15):1160. doi: 10.1038/s41388-024-02983-9.

X Q Zheng^#^{1

2

3}, J P Guo^#¹, H Yang¹, M Kanai¹, L L He¹, Y Y Li¹, J M Koomen¹, S Minton⁴, M Gao², X B Ren³, D Coppola⁵, J Q Cheng⁶

¹ Department of Molecular Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
² Departments of Thyroid and Neck Tumour, Tianjin Medical University Cancer Institute and Hospital, Oncology Key Laboratory of cancer prevention and therapy, National Clinical Research Center of Cancer, Tianjin, PR China.
³ Department of Immunology, Tianjin Medical University Cancer Institute and Hospital, Oncology Key Laboratory of cancer prevention and therapy, National Clinical Research Center of Cancer, Tianjin, PR China.
⁴ Departments of Women's Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
⁵ Departments of Women's Pathology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA.
⁶ Department of Molecular Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. jin.cheng@moffitt.org.

^# Contributed equally.

No abstract available

Publication types